SLNO
SOLENO THERAPEUTICS INC
undefined Pharmaceutical Preparations Large accelerated filer

Key Financials

Net Income
$20.9M
↑ 111.9%
Gross Profit
$-58518
↓ 123.0%
Operating Income
$9.4M
↑ 105.0%
Revenue
$4000
N/A
Total Assets
$563.8M
↑ 70.4%
EPS (Diluted)
$0.39
↑ 108.9%
Shareholders' Equity
$450.1M
↑ 83.6%
Total Liabilities
$113.7M
↑ 32.4%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G/A 8/13/2026 View on SEC
15-12G 5/28/2026 View on SEC
EFFECT 5/27/2026 View on SEC
POS AM 5/21/2026 View on SEC
AW 5/21/2026 View on SEC
4 5/18/2026 View on SEC
4 5/18/2026 View on SEC
4 5/18/2026 View on SEC
4 5/18/2026 View on SEC
4 5/18/2026 View on SEC

Company Information

Field Value
Ticker SLNO
Company Name SOLENO THERAPEUTICS INC
CIK 1484565
Sector Pharmaceutical Preparations
Industry Large accelerated filer
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 650-213-8444